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Abstract
Background Psychotropic drug use in Europe and the
USA has increased in the past 20 years. The rise in mental
health-care use instigated a debate about possible differ-
ences in prevalence rates between different ethnic groups
in the Netherlands, although the exact differences were
unknown. The aim of this study was to determine whether
these minority groups were more or less likely than the
native population to receive psychotropic drugs.
Methods A descriptive population study was conducted
using the Agis Health Database, containing demographic
and health-care consumption data of approximately
1.5 million inhabitants of the Netherlands. Rates of pre-
scriptions of psychotropic drugs from 2001 to 2006 and
adjusted odds ratios for psychotropic drug prescriptions
among native Dutch, Turkish and Moroccan ethnic groups
were calculated. These data were analysed using logistic
regression, after being adjusted for age, gender and
socioeconomic status.
Results The mean year prevalence of psychotropic drug
prescriptions from 2001 to 2006 was 14.0%. Except for a
decrease in anxiolytic drugs, the prescriptions of psycho-
tropic drugs increased from 2001 to 2006. These trends
were the same for all of the ethnic groups considered.
Among both the Moroccan and Turkish populations, there
was a higher risk of antidepressant and antipsychotic drug
prescriptions, and a pronounced lower risk of ADHD
medication and lithium prescriptions compared to the
native population. Among the Turkish population, the risk
of anxiolytic drug prescriptions was greater than in the
native population.
Conclusions Compared to the native population in the
Netherlands, first- and second-generation Turkish and
Moroccan immigrants had an increased risk of antide-
pressant and antipsychotic drug prescriptions and a
decreased risk of ADHD medication and Lithium pre-
scriptions. Further research is needed to clarify whether
patients of different ethnic backgrounds with the same
symptoms receive similar diagnosis and adequate
treatment.
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Introduction
With the availability of specific psychotropic drugs, mental
health treatment in primary care has been more accepted.
In Europe and the USA, the prevalence of psychotropic
drug use has increased in the last 20 years [2, 8]. In the
Netherlands, the number of patients who were prescribed
psychotropic drugs was recently estimated to be up to 7.4%
of the total population per year [1]. In 52% of the cases,
psychotropic drugs were prescribed by general practitio-
ners (GPs) [9]. The type of prescribed psychotropic drugs
can be used as a proxy indicator to estimate the prevalence
of different mental disorders.
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Following the increase of mental disorders, the preva-
lence of distribution among different ethnic immigrant
groups was also considered. Harrison et al. found an
increased incidence of schizophrenia in immigrants from
the African Caribbean in the UK [6]. After this publication,
several studies on differences in the prevalence and inci-
dence rates among immigrants in western Europe followed.
The two large immigrant groups in western Europe are
Turks and Moroccans, who immigrated to the Netherlands,
Belgium, Germany and France in the 1960s and 1970s of
the twentieth century, when an excess of jobs in these
countries invited immigration.
Since the start of the Turkish and Moroccan immigra-
tion, the composition of ethnic groups in the Netherlands
has shifted. Nowadays, the growth of the native Dutch
population has almost stopped (\0.1%), while the non-
Western population in the Netherlands increases by 1.2%
each year. The Turkish and Moroccan communities now
represent, respectively, 2.2 and 2.0% of the total population
of over 16 million people [17]. The proportional growth of
the Turkish and Moroccan minority groups emphasizes the
need for more accurate knowledge of prevalence rates and
treatment of mental disorders in these groups.
Belgian and Dutch studies on differences in prevalence
and incidence rates show an increased risk of depressive
symptoms in Moroccan and Turkish immigrants [7, 23], an
increased risk of manic-depressive psychosis in Moroccan
and Turkish men and a decreased risk of manic-depressive
psychosis in Moroccan and Turkish women [12]. The risk
of anxiety symptoms in Moroccan and Turkish immigrants
was heightened [7]. An increased risk of schizophrenia in
(male) Moroccan immigrants was found; the risk of
Turkish immigrants for schizophrenia were equal [3, 5, 10,
13–15] or enhanced compared to the native population
[21]. These studies, however, mostly investigated specific
psychiatric disorders and often included only patients
receiving specialized care in specific parts of the Nether-
lands, such as larger cities. Since in the Netherlands, 86%
of the total mental disorders are diagnosed and treated by
GPs [9] and the Turkish and Moroccan ethnic groups do
not exclusively live in the largest cities of the country,
these results are expected to contain some bias.
Because it was established that the prevalence of some
psychiatric disorders was higher in the Moroccan and
Turkish ethnic groups, the aim of this study was to deter-
mine whether these minority groups received more psy-
chotropic drugs, or less.
A large population study on the differences in the
prevalence of psychotropic drug prescriptions for mental
health disorders among minority groups in the Netherlands
in ambulant care was conducted. The evaluation of psy-
chotropic drugs over a 6-year period from 2001 to 2006 is
presented in this study.
Methods
Data
The data used were taken from the Agis Health Database.
Agis is a major health insurance company in the centre of
the Netherlands. The Agis database contains the demo-
graphic and health-care consumption data of approximately
1.5 million inhabitants. The Agis Health Database has an
accurate registration of all pharmaceutical prescriptions.
Inhabitants of the Netherlands are obliged by law to get
medical insurance. All psychotropic drugs are those which
are available only on doctor’s prescription. Almost every
inhabitant has a GP, who is the gatekeeper to secondary
care, including mental health care. Both GPs and psychi-
atrists prescribe psychotropic drugs. All prescriptions by
GPs and psychiatrists must be registered electronically in
this database before costs are reimbursed by the health
insurance company. All insured patients from 1 January
2001 to 31 December 2006 living in the cities of Amster-
dam, Utrecht, Amersfoort, Apeldoorn and surrounding
(rural) areas were included. Ethical approval for the study
was not required, since the data were routinely collected
and anonymous.
Ethnicity
While the Agis Health Database does not register ethnicity,
it does register foreign nationality. Therefore, the first-
generation Moroccan and Turkish immigrants were regis-
tered with their nationality and were therefore easily
categorized. By matching the surnames of the selected
Moroccan and Turkish immigrants with the remaining
subjects in the database, the second- and third-generation
immigrants could be selected as well. Ethnic groups were
defined as: ‘‘Turkish’’, ‘‘Moroccan’’ and ‘‘native’’. The
‘‘native’’ group consisted of subjects of Dutch and Western
nationalities (98.7%) and other non-Western nationalities
(1.3%).
Psychotropic drugs
Prescriptions for psychotropic drugs to these patients were
extracted according to the Anatomical Therapeutic
Chemical (ATC) classification system codes. All pre-
scribed drugs with ATC codes starting with N05A (anti-
psychotic drugs), N05B (anxiolytic drugs) and N06A
(antidepressant drugs), and ATC codes N06BA04 (meth-
ylphenidate), N06BA09 (atomoxetine; ADHD medicine)
and N05AN01 (lithium) were included.
Where an individual received more than one prescrip-
tion in a year, the individual was represented only once that
year. When the individual received prescriptions of more
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than one subgroup, the individual was represented in both
subgroups. Such an individual was represented only once
in the prevalence rate of the ‘‘psychotropic drugs’’
category.
Covariates
The following data were obtained of each insured person:
age, gender, mean income and urbanization grade of the
living area as a proxy of socioeconomic status. The postal
code was used to derive the grade of urbanization and mean
income per person, as defined and registered by Statistics
Netherlands (CBS) [17]. Since the incomes were normally
distributed, the population was divided into three groups:
low income (below one standard deviation from the mean);
middle income (between one standard deviation below the
mean and one standard deviation above the mean); high
income (above one standard deviation from the mean). A
few neighbourhoods with missing CBS income data were
given the mean income value. All prescribed drugs with
ATC codes starting with N05A ‘‘antipsychotic drugs’’,
N05B ‘‘anxiolytic drugs’’, N06A ‘‘antidepressant drugs’’
and ATC codes N06BA04, atomoxetine, N06BA09,
methylphenidate (‘‘ADHD medicine:) and N05AN01,
‘‘lithium’’, were included.
Analyses
The prevalence of total psychotropic drug prescriptions, as
well as the prevalence of the prescriptions of drugs of
subgroups of psychotropic drugs, were calculated for every
year from 2001 to 2006. A logistic regression analysis was
used to calculate the crude and adjusted odds ratios of
psychotropic drug prescriptions in the different minority
groups in 2006. A separate logistic regression analysis was
performed for each drug group. The analysis was per-
formed using the native group as a reference category and
including the following covariates: age, sex, grade of
urbanization and mean income. Additional logistic
regression analyses were done for each age group, per
different drug group. SPSS version 14.0.1 was used for the
analyses.
Results
A total number of 1,220,338 medically insured subjects
were included, varying between 852,213 and 1,024,627
insured subjects per year. In 2006, 12.2% of the subjects
belonged to the Moroccan group, 7.2% to the Turkish
group and 80.6% to the native Dutch group. In 2006, the
Turkish and Moroccan groups were significantly younger,
had a lower income and lived in more urbanized areas in
the Netherlands compared with the native Dutch group
(Table 1).
As shown in Table 2, from 2001 to 2006, there was an
increase in the prevalence of prescription of antipsychotics,
antidepressants, ADHD medications and lithium. The
prevalence of anxiolytic drug prescriptions decreased;
however, the mean year prevalence of psychotropic drug
prescriptions from 2001 to 2006 was 14.0%. These pre-
scription trends were similar in all minority groups
(Fig. 1).
After multivariate adjustment (Table 3), a slightly
higher risk of antipsychotic drug prescriptions was seen
among the Moroccan and Turkish populations compared to
the native Dutch population. The risk of anxiolytic drug
prescriptions among the Turkish population was also
somewhat higher. The Moroccan population, on the other
hand, had a lower risk of anxiolytic drug prescriptions than
the native Dutch population. There was a higher risk of
antidepressant drug prescriptions among the Moroccan and
Turkish populations in the Netherlands compared with the
native Dutch population (Table 3). Among the Turkish
population aged 40–59, the odds ratio was even higher
[2.15 (95%CI 2.05–2.25], compared to the Dutch popula-
tion of the same age group. The risk of ADHD medication
prescriptions was markedly lower for the Moroccan and
Turkish populations than the native Dutch population. The
risk of receiving lithium prescriptions was also much lower
for the Moroccan and Turkish populations than the native
Dutch population (Table 3). The selected covariates were
of great influence on all odds ratios. In the Turkish ethnic
group, for example, the crude odds ratio for anxiolytic
drugs prescriptions was 0.75, but after adjustment for age,
sex, grade of urbanization and income, the odds ratio
became 1.27.
The variable interfering most with ethnicity was age,
followed by gender, income and finally urbanization. The
risk of psychotropic drug prescriptions was especially
increased among the Turkish population aged 40–59 years,
compared with the native population of the same age
group, with an adjusted odds ratio of 1.63 (95%CI 1.57–
1.70). Children aged 0–17 of both Moroccan and the
Turkish ethnic groups had a lower risk of psychotropic
drugs prescriptions compared to children of the same age
of the Dutch ethnic group, with odds ratios of 0.42 (95%CI
0.37–0.48) and 0.42 (95%CI 0.36–0.49), respectively.
Except for anxiolytic drugs, this difference was found with
regard to all psychotropic drugs among this age group.
Discussion
In this study, evidence was obtained on differences in the
prescriptions of psychotropic drugs among different
Soc Psychiat Epidemiol (2010) 45:819–826 821
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immigrant groups in the Netherlands, as compared to the
native population. Prescription of psychotropic drugs was
more prevalent in 2006 than in the previous years, except
for prescriptions of anxiolytic drugs, which showed a
decline. Although these trends were the same for all ethnic
groups, several differences between the groups could be
demonstrated. After adjustment for co-variables, both the
Moroccan and Turkish populations had a higher risk of
antidepressant and antipsychotic drug prescriptions than
the native population in the Netherlands. Furthermore,
anxiolytic drug prescriptions were relatively more common
in the Turkish population. In contrast, the rate of ADHD
medication prescriptions and lithium prescriptions among
both the Moroccan and Turkish ethnic groups was notably
lower than among the native Dutch population.
The results of this study partly contradict previous
research, but confirm some of the other results. Our study
confirmed higher depression rates among the elderly
Moroccan and Turkish immigrants as demonstrated previ-
ously in a Belgian and a Dutch study [7, 23]. Although the
risk of antipsychotic drug prescriptions among Moroccans
was higher than in the native Dutch population, the risk
was lower than expected according to the incidence rates
among immigrants. On the contrary, the risk of antipsy-
chotic drug prescriptions among the Turkish ethnic group
was higher than expected, according to incidence rates
among immigrants [3, 10, 13, 15].
The lower number of prescriptions of ADHD medication
among the Turkish and Moroccans are comparable with the
results demonstrated by Zwirs et al. [24, 25]. Their socio-
cultural explanation was that there is a higher treatment
threshold for behavioural problems in Turkish and Moroccan
children than in the native population, as well as a lower
sensitivity of their parents in detecting behavioural problems
such as ADHD. The possible under-treatment of ADHD in
immigrants poses questions. Is untreated ADHD in immi-
grant populations one of the explanations for behavioural
problems of immigrant children and teenagers as seen in the
Netherlands? Are the differences in ADHD medication
prescriptions caused by health insurance policies, which
reimburse only for short-acting methylphenidate, but not for
ADHD medication with a long-acting profile?
This large population study will have prevented some of
the selection bias that occurred in the previous studies on
specific age or patient groups [3, 7, 10, 12–15, 21, 23–25].
The Agis database for example included enough data on
the relatively small group of older adults (e.g. 60?):
Turkish and Moroccan minority groups.
Other possible explanations for the risk differences in
psychotropic drug prescriptions among Moroccan and
Table 1 Characteristics of the different ethnic groups
Moroccan ethnicity Turkish ethnicity Native ethnicity Total
Year [n (%)]
2001 89,769 (9.2) 55,194 (5.6) 835,348 (85.2) 980,311
2002 95,006 (9.3) 58,080 (5.7) 867,482 (85.0) 1,020,568
2003 99,539 (9.7) 60,306 (5.9) 864,782 (84.4) 1,024,627
2004 101,302 (10.2) 61,030 (6.2) 829,340 (83.6) 991,672
2005 102,551 (10.6) 61,682 (6.4) 829,340 (83.6) 963,706
2006 103,886 (12.2) 61,339 (7.2) 686,988 (80.6) 852,213
For 2006
Gender (m/f) 52.2/47.8 51.4/48.6 45.7/54.3 46.9/53.1
Age, mean [SD (range)] 27 [19 (0–96)] 29 [18 (0–96)] 44 [23 (0–111)] 40 [23 (0–111)]
0–17 years (%) 38,793 (37.3) 20,425 (33.3) 114,029 (16.6) 173,247 (20.3)
18–39 years (%) 37,601 (36.2) 23,375 (38.1) 186,551 (27.2) 247,527 (29.0)
40–59 years (%) 20,015 (19.3) 13,238 (21.6) 199,954 (29.1) 233,207 (27.4)
60? years (%) 7,477 (7.2) 4,301 (7.0) 186,454 (27.1) 198,232 (23.3)
Income, mean [SD (range)] 10.7 [1.4 (7.6–22)] 10.6 [1.3 (7.6–22)] 11.4 [1.7 (7.6–22)] 11.3 [1.7 (7.6–22)]
Urbanization grade [n (%)]
I and II 2,645 (2.5) 1,985 (3.2) 86,688 (12.6) 91,318 (10.7)
III 5,851 (5.6) 4,574 (7.5) 93,827 (13.7) 104,252 (12.2)
IV and V 95,390 (91.8) 54,780 (89.3) 506,472 (73.7) 656,642 (77.1)
Income = income 9 1,000 in Euros per year (mean per person per postal code area). Urbanization grade as defined by Statistics Netherlands
(CBS): I fewer than 500 addresses/km2, II 500–1,000 addresses/km2, III 1,000–1,500 addresses/km2, IV 1,500–2,500 addresses/km2, V over
2,500 addresses/km2. Native denotes subjects with Dutch and Western nationalities (98.7%) and other non-Western nationalities (1.3%)
N number of insured, m male, f female
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Turkish groups are: different occurrence rates of mental ill-
nesses, different approaches by medical professionals and
culturally defined coping strategies for stressors and mental
illnesses [22]. The latter explanation is associated with the
cultural conflict that arises from living between two cultures,
which results in a higher exposure to stressors for the second-
generation immigrants, such as a chronic experience of
social defeat, discrimination and perceived discrimination,
and lower social status [5, 11]. It has also been suggested that
differences in substance abuse could cause higher schizo-
phrenia rates [20]. The result of ageing of the first-generation
immigrants will be a higher prevalence of chronic illnesses
and lower physical well-being, causing higher rates of
mental illnesses. Another explanation for differences in
prescribed drug usage is a lower perceived need for care by
Moroccan and Turkish ethnic groups in the Netherlands,
which leads to less help-seeking behaviour and hence fewer
prescriptions [4]. Finally, there is little systematic knowl-
edge of professionals’ approaches to the behaviour of dif-
ferent ethnic groups and their mental illnesses [19].
This study showed that controlling for age, gender,
income and urbanization had a big influence on outcomes.
Age was the most prominent factor. Because of the rela-
tively recent immigration of the Turkish and Moroccan
labourers at a working age (in the 1960s and 1970s of the
twentieth century), the Moroccan and Turkish ethnic
groups are younger of age than the native Dutch popula-
tion. As the prevalences of the different psychiatric disor-
ders are not equally distributed among all age groups, the
importance of the age factor is demonstrated in this study
Table 2 Prevalence trends of psychotropic drug and psychotropic drug subgroup prescriptions, overall and within ethnic groups (%)
Year 2001 2002 2003 2004 2005 2006
N total 980,311 1,020,568 1,024,627 991,672 963,706 852,213
N Moroccan 89,769 95,006 99,539 101,302 102,551 103,886
N Turkish 55,194 58,080 60,306 61,030 61,682 61,339
N native 835,348 867,482 864,782 829,340 799,473 686,988
Psychotropic drugs 14.1 14.1 14.0 14.0 13.7 14.1
Moroccan 9.8 9.7 9.5 9.4 9.3 9.4
Turkish 13.2 13.1 12.6 12.4 12.0 12.6
Native 14.7 14.7 14.6 14.7 14.4 14.9
Antipsychotic drugs 1.6 1.7 1.9 2.0 2.1 2.4
Moroccan 1.6 1.6 1.7 1.8 1.9 2.1
Turkish 1.5 1.6 1.7 1.8 2.0 2.1
Native 1.6 1.8 1.9 2.1 2.1 2.5
Anxiolytic drugs 9.6 9.4 9.1 8.7 8.5 8.5
Moroccan 6.1 5.8 5.4 5.0 5.0 4.8
Turkish 8.7 8.4 7.7 7.2 6.9 7.1
Native 10.1 9.8 9.6 9.2 9.1 9.2
Antidepressant drugs 6.1 6.3 6.3 6.8 6.4 6.9
Moroccan 4.9 5.1 5.1 5.4 5.4 5.7
Turkish 7.1 7.3 7.3 7.7 7.4 8.0
Native 6.2 6.4 6.4 6.9 6.5 7.0
ADHD medication 0.18 0.20 0.24 0.26 0.29 0.32
Moroccan 0.09 0.09 0.11 0.13 0.16 0.15
Turkish 0.06 0.07 0.08 0.08 0.10 0.11
Native 0.20 0.22 0.26 0.29 0.33 0.36
Lithium 0.21 0.22 0.22 0.23 0.24 0.25
Moroccan 0.04 0.04 0.04 0.05 0.05 0.06
Turkish 0.06 0.06 0.05 0.07 0.09 0.09
Native 0.24 0.25 0.25 0.26 0.27 0.30
‘‘Antipsychotic drugs’’ have ATC codes starting with N05A. ‘‘Anxiolytic drugs’’ have ATC codes starting with N05B. ‘‘Antidepressant drugs’’
have ATC codes starting with N06A, ‘‘ADHD medication’’ are methylphenidate and atomoxetine and ‘‘lithium’’ is ATC code N05AN01. Where
an individual received more than one prescription in a year, the individual was represented only once that year. When the individual received
prescriptions of more than one subgroup, the individual was represented in both subgroups. Such an individual was represented only once in the
prevalence rate of the ‘‘psychotropic drugs’’ category
Soc Psychiat Epidemiol (2010) 45:819–826 823
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where after adjustment, the risk of antipsychotic and anti-
depressant drug prescriptions for Moroccan and Turkish
patients shifted from a lower risk, than for the native Dutch
population, to a higher one.
To assess the value of the present results, the limitations
of the study need to be discussed. First, some prominent
ethnic groups of immigrants with a Dutch nationality, from
Surinam, the Netherlands Antilles and Aruba could not be
evaluated. Selten et al. demonstrated that the incidence of
schizophrenia in the Surinam and Netherlands Antillean
population is two to five times higher than in the native
Dutch population [14]. The high percentage of people from
Surinam (2.9%, 331,890) and the Antilles (0.8%, 129,683)
in 2006 [17], who were now included in the native Dutch
group, could have led to an overestimation of the preva-
lence of drug prescriptions to this group.
Second, this study used psychotropic drug prescriptions
as a proxy indicator for mental disorders. There might be a
difference in the prescription of psychotropic drugs, by
GPs and psychiatrists, for mental disorders, to different
ethnic groups, such as the investigated different treatment
threshold for ADHD [25]. Also, off-label prescriptions are
common among all psychotropic drug groups, except for
ADHD medication.
Third, data on income are based on the mean income of
a neighbourhood. When the immigrant population is
Fig. 1 Prevalence of psychotropic drug prescriptions and differences
within ethnic groups. It shows the comparison among the major
psychotropic drug groups
Table 3 Risks of psychotropic drug and psychotropic drug subgroup prescriptions among different ethnic groups in 2006
Variable Persons who received
a prescription (%)
Crude OR 95%CI Adjusted OR 95%CI
Psychotropic drugs
Moroccan 9,801 (9.4) 0.60 0.58–0.61 1.01 0.98–1.03
Turkish 7,688 (12.5) 0.82 0.80–0.84 1.32 1.29–1.36
Native 102,294 (14.9) 1.0 1.0
Antipsychotic drugs
Moroccan 2,121 (2.0) 0.84 0.80–0.88 1.15 1.10–1.21
Turkish 1,270 (2.1) 0.85 0.80–0.90 1.12 1.05–1.18
Native 16,709 (2.4) 1.0 1.0
Anxiolytic drugs
Moroccan 4,966 (4.8) 0.50 0.48–0.51 0.88 0.85–0.91
Turkish 4,341 (7.1) 0.75 0.73–0.78 1.27 1.23–1.31
Native 63,119 (9.2) 1.0 1.0
Antidepressant drugs
Moroccan 5,935 (5.7) 0.80 0.78–0.83 1.37 1.33–1.41
Turkish 4,918 (8.0) 1.16 1.12–1.19 1.85 1.79–1.91
Native 48,219 (7.0) 1.0 1.0
ADHD medication
Moroccan 152 (0.15) 0.40 0.34–0.48 0.26 0.22–0.30
Turkish 70 (0.11) 0.31 0.25–0.40 0.21 0.16–0.27
Native 2,487 (0.36) 1.0 1.0
Lithium
Moroccan 62 (0.06) 0.20 0.16–0.26 0.23 0.17–0.29
Turkish 56 (0.09) 0.31 0.24–0.40 0.34 0.26–0.45
Native 2,033 (0.30) 1.0 1.0
N Moroccan = 103,886, N Turkish = 61,339 and N native = 686,988. Adjusting factors were: gender, age, income and urbanization grade
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clustered on the lower end of the income scale, the effect of
this important risk factor could be underestimated. It would
mean that the risk differences between the ethnic groups
might be less profound.
Fourth, the data used here are based on insured persons;
uninsured persons were not included in this study. Inhab-
itants of the Netherlands are obliged by law to get medical
insurance; however, 1.0% of the population is still unin-
sured. First-generation immigrants are uninsured more
often than other inhabitants of the Netherlands. Analyses
by Statistics Netherlands showed that 1.3% of Moroccan
immigrants and 1.4% of Turkish immigrants were unin-
sured, in contrast to 0.4% of the native Dutch population
[18]. It is unclear whether the uninsured Turkish and
Moroccan immigrants had a higher or lower risk of getting
prescribed psychotropic drugs than others; hence, one
cannot say whether the present results are an underesti-
mation or overestimation.
Fifth, surnames were used to identify the different ethnic
groups. This is not an infallible method, as marriages of
mixed ethnicity may bias the results, and immigrants might
change their surnames to ‘‘integrate’’ ‘‘better.’’ However,
mixed marriages are exceptions in the Netherlands. In
2003, 85.2% of the married Turkish women in the Neth-
erlands had married Turkish men and 75.5% of married
Moroccan women had married Moroccan men. 76.2% of
the Turkish men married Turkish women and 73.5% of the
Moroccan men married Moroccan women [16]. In addition,
in the Netherlands it is not common for the Turkish and
Moroccan ethnic groups to change their surnames to fit in
better.
The results of this study imply that, since the proportion
of Turks and Moroccans in the Netherlands is still growing,
mental health care must be prepared for a shift in preva-
lence rates of the different mental disorders. Moroccan
immigration did not only take place in the Netherlands, but
also in large numbers in Belgium, Germany, France,
Denmark, Italy, Spain, the UK and Norway. Turkish
immigration was also high in Germany, Belgium, Austria,
France and Sweden. These countries will probably
encounter the same problems in mental health care that are
occurring in the Netherlands.
In this study, anti-dementia drugs were not included.
Differences in dementia incidence rates and associated
health-care consumption in the Turkish and Moroccan
immigrant groups have not been investigated yet and may
be an interesting subject for additional research.
Further research is needed to clarify if patients of dif-
ferent ethnic backgrounds with the same symptoms receive
similar diagnosis and adequate treatment. If inequalities are
found, this would point to a need for extra education and
specialized mental health-care programs for ethnic minor-
ities. To develop effective prevention and treatment
programmes, further research seems warranted, especially
on differences in genetic risk factors and exposure to
environmental risk factors among the different ethnic
groups.
Conclusions
Turkish and Moroccan first- and second-generation immi-
grants have an increased risk of antidepressant and anti-
psychotic drug prescriptions and a decreased risk of ADHD
medication prescriptions and Lithium prescriptions, as
compared to the native Dutch population in the Nether-
lands. With the increasing proportion of Turkish and
Moroccan first-, second- and third-generation immigrants
in the Netherlands, these differences will become more
visible in mental health care in the near future. With an
increase in the number of immigrants, the risk prevalence
rates are also expected to change over time. To provide
optimal care and be able to prevent mental health prob-
lems, the causes of differences in mental health-care con-
sumption between immigrant populations and the native
Dutch population require further investigation. Also, the
causes of differences between ADHD medication pre-
scriptions among immigrants, their children and the native
population need to be explored further. Such research
should make clear if the threshold for treating children with
ADHD must be lowered for the Turkish and Moroccan
populations to provide equal care and equal chances for
these children. GPs and psychiatrists may benefit from
more awareness of the differences in mental health among
the different minority groups, to improve their practice.
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